Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Adrenic Acid (22:4, n-6) (CAS 28874-58-0)

0.0(0)
Write a reviewAsk a question

See product citations (2)

Alternate Names:
cis-7,10,13,16-Docosatetraenoic acid
Application:
Adrenic Acid (22:4, n-6) is a polyunsaturated fatty acid believed to be a source of arachidonic acid
CAS Number:
28874-58-0
Purity:
≥96%
Molecular Weight:
332.5
Molecular Formula:
C22H36O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Adrenic Acid (22-4,n-6), also known as 7,10,13,16-Docosatetraenoic acid, is a polyunsaturated fatty acid. Peroximal beta-oxidation of Adrenic Acid (22:4, n-6) may act to form arachidonic acid. Endothelial cells have been shown to convert arachidonic acid to docosatetraenoic acid and releasing docosatetraenoic acid when exposed to ionophore A23187 (sc-3591). Additionally, endothelial cell studies have demonstrated that adrenic acid reduces prostaglandin 12.


Adrenic Acid (22:4, n-6) (CAS 28874-58-0) References

  1. Lipids in blood-brain barrier models in vitro II: Influence of glial cells on lipid classes and lipid fatty acids.  |  Krämer, SD., et al. 2002. In Vitro Cell Dev Biol Anim. 38: 566-71. PMID: 12762838
  2. Identification of two novel microalgal enzymes involved in the conversion of the omega3-fatty acid, eicosapentaenoic acid, into docosahexaenoic acid.  |  Pereira, SL., et al. 2004. Biochem J. 384: 357-66. PMID: 15307817
  3. Priming effect of adrenic acid (22:4(n-6)) on tissue factor activity expressed by thrombin-stimulated endothelial cells.  |  Tardy, B., et al. 1992. Atherosclerosis. 95: 51-8. PMID: 1642692
  4. Arachidonate-derived dihomoprostaglandin production observed in endotoxin-stimulated macrophage-like cells.  |  Harkewicz, R., et al. 2007. J Biol Chem. 282: 2899-910. PMID: 17135246
  5. Chronic risperidone normalizes elevated pro-inflammatory cytokine and C-reactive protein production in omega-3 fatty acid deficient rats.  |  McNamara, RK., et al. 2011. Eur J Pharmacol. 652: 152-6. PMID: 21118685
  6. Adrenoleukodystrophy. The chain shortening of erucic acid (22:1(n-9)) and adrenic acid (22:4(n-6)) is deficient in neonatal adrenoleukodystrophy and normal in X-linked adrenoleukodistrophy skin fibroblasts.  |  Christensen, E., et al. 1989. Biochim Biophys Acta. 1002: 79-83. PMID: 2538146
  7. Evidence for peroxisomal retroconversion of adrenic acid (22:4(n-6)) and docosahexaenoic acids (22:6(n-3)) in isolated liver cells.  |  Hagve, TA. and Christophersen, BO. 1986. Biochim Biophys Acta. 875: 165-73. PMID: 2935195
  8. Exposure to a Farm Environment During Pregnancy Increases the Proportion of Arachidonic Acid in the Cord Sera of Offspring.  |  Barman, M., et al. 2019. Nutrients. 11: PMID: 30678238
  9. Docosatetraenoic acid in endothelial cells: formation, retroconversion to arachidonic acid, and effect on prostacyclin production.  |  Mann, CJ., et al. 1986. Arch Biochem Biophys. 244: 813-23. PMID: 3080955
  10. The Zellweger syndrome: deficient chain-shortening of erucic acid (22:1 (n-9)) and adrenic acid (22:4 (n-6)) in cultured skin fibroblasts.  |  Christensen, E., et al. 1988. Biochim Biophys Acta. 959: 134-42. PMID: 3349094
  11. Synthesis of dihomoprostaglandins from adrenic acid (7,10,13,16-docosatetraenoic acid) by human endothelial cells.  |  Campbell, WB., et al. 1985. Biochim Biophys Acta. 837: 67-76. PMID: 3931686
  12. Arachidonic acid formed by peroxisomal beta-oxidation of 7,10,13,16-docosatetraenoic acid is esterified into 1-acyl-sn-glycero-3-phosphocholine by microsomes.  |  Baykousheva, SP., et al. 1994. J Biol Chem. 269: 18390-4. PMID: 8034586
  13. Fate of linoleic, arachidonic, and docosa-7,10,13,16-tetraenoic acids in rat testicles.  |  Ayala, S., et al. 1973. J Lipid Res. 14: 296-305. PMID: 9704073

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Adrenic Acid (22:4, n-6), 25 mg

sc-200784
25 mg
$209.00

Adrenic Acid (22:4, n-6), 100 mg

sc-200784A
100 mg
$639.00